Since the HER2-CD3-Fc mRNA-LNPs exhibited potent T-cell-dependent killing of HER2-positive tumor cells in vitro, we examined whether the mRNA-LNPs would exert an antitumor effect against A1847 tumor cells in the NSG mouse xenograft model [67]. The gene discussed is ERBB2; the disease is neoplasm.